Sanjay Subramanian is SVP, CFO of Inozyme Pharma, Inc.. Currently has a direct ownership of 30,398 shares of INZY, which is worth approximately $91,497. The most recent transaction as insider was on Sep 29, 2023, when has been sold 2,319 shares (Common Stock) at a price of $3.57 per share, resulting in proceeds of $8,278. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.4K
0% 3M change
0% 12M change
Total Value Held $91,497

Sanjay Subramanian Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 29 2023
BUY
Grant, award, or other acquisition
$8,278 $3.57 p/Share
2,319 Added 7.09%
30,398 Common Stock
Mar 31 2023
BUY
Grant, award, or other acquisition
$2,163 $2.21 p/Share
979 Added 3.37%
28,079 Common Stock
Apr 19 2022
BUY
Open market or private purchase
$99,999 $3.69 p/Share
27,100 Added 50.0%
27,100 Common Stock

Also insider at

OCGN
Ocugen, Inc. Healthcare
SS

Sanjay Subramanian

SVP, CFO
Malvern, PA

Track Institutional and Insider Activities on INZY

Follow Inozyme Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INZY shares.

Notify only if

Insider Trading

Get notified when an Inozyme Pharma, Inc. insider buys or sells INZY shares.

Notify only if

News

Receive news related to Inozyme Pharma, Inc.

Track Activities on INZY